Ronald P. Gladue

3.7k citations

40 papers · 3.0k indexed · 1 hit paper · h-index 26

Co-authors: Kuldeep Neote M F Newborg G. Michael Bright Richard E. Isaacson Timothy Paradis Christine A. Strick James G. Boyd Shaun R. McColl
Topics: Chemokine receptors and signaling (17 papers)Immunotherapy and Immune Responses (13 papers)T-cell and B-cell Immunology (13 papers)
Cited by: Immunology Immunology and Allergy Oncology
Journals: Journal of Biological Chemistry The Journal of Experimental Medicine Journal of Clinical Oncology
Partner nations: United States Australia Canada

In The Last Decade

Ronald P. Gladue

40 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interferon–inducible T Cell Alpha Chemoattractant (I-TAC): A Novel Non-ELR CXC Chemokine with Potent Activity on Activated T Cells through Selective High Affinity Binding to CXCR3

1998 744 citations Timothy Paradis, Ronald P. Gladue et al. The Journal of Experimental Medicine profile →

Peers

Countries citing papers authored by Ronald P. Gladue

Since Specialization

Citations

This map shows the geographic impact of Ronald P. Gladue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald P. Gladue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald P. Gladue more than expected).

Fields of papers citing papers by Ronald P. Gladue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald P. Gladue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald P. Gladue. The network helps show where Ronald P. Gladue may publish in the future.

Co-authorship network of co-authors of Ronald P. Gladue

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald P. Gladue. A scholar is included among the top collaborators of Ronald P. Gladue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald P. Gladue. Ronald P. Gladue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The CD40 agonist antibody CP-870,893 enhances dendritic cell and B-cell activity and promotes anti-tumor efficacy in SCID-hu mice 2011 ·Cancer Immunology Immunotherapy ·Ronald P. Gladue,Timothy Paradis,(unknown),Carol Donovan,(unknown),(unknown),(unknown),(unknown),Eileen A. Elliott,Richard M. Shepard,Vahe Bedian	55
2	CCR1 Antagonists: What Have We Learned From Clinical Trials 2010 ·Current Topics in Medicinal Chemistry ·Ronald P. Gladue,Matthew F. Brown,Samuel H. Zwillich	65
3	CCR2 receptor blockade alters blood monocyte subpopulations but does not affect atherosclerotic lesions in apoE−/− mice 2009 ·Atherosclerosis ·Robert J. Aiello,(unknown),Patricia-Ann K. Bourassa,Andrew Robertson,Weifan Weng,Delvin R. Knight,Andrew H. Smith,Kosea S. Frederick,Amit S. Kalgutkar,Ronald P. Gladue	37
4	An Agonist Antibody Specific for CD40 Induces Dendritic Cell Maturation and Promotes Autologous Anti‐tumour T‐cell Responses in an In vitro Mixed Autologous Tumour Cell/Lymph Node Cell Model 2007 ·Scandinavian Journal of Immunology ·Terri Hunter,Marwan Alsarraj,Ronald P. Gladue,Vahe Bedian,Scott Antonia	34
5	Essential Role of CCR6 in Directing Activated T Cells to the Skin during Contact Hypersensitivity 2007 ·Journal of Investigative Dermatology ·Timothy Paradis,(unknown),(unknown),Ronald P. Gladue	31
6	The Human Specific CCR1 Antagonist CP-481,715 Inhibits Cell Infiltration and Inflammatory Responses in Human CCR1 Transgenic Mice 2006 ·The Journal of Immunology ·Ronald P. Gladue,(unknown),Marsha L. Roach,Laurie Tylaska,(unknown),Richard M. Shepard,John D. McNeish,(unknown),Kuldeep Neote	33
7	Potent small molecule CCR1 antagonists 2004 ·Bioorganic & Medicinal Chemistry Letters ·John C. Kath,William H. Brissette,Matthew F. Brown,Maryrose J. Conklyn,(unknown),Peter H. Dorff,Ronald P. Gladue,Brett M. Lillie,Paul D. Lira,(unknown),William H. Martin,Eric B. McElroy,(unknown),Timothy Paradis,Christopher S. Poss,Ingrid A. Stock,Laurie Tylaska,(unknown)	17
8	The discovery of structurally novel CCR1 antagonists derived from a hydroxyethylene peptide isostere template 2004 ·Bioorganic & Medicinal Chemistry Letters ·John C. Kath,(unknown),Ronald P. Gladue,William H. Martin,Eric B. McElroy,Ingrid A. Stock,Laurie Tylaska,(unknown)	17
9	CCR2 REGULATES THE LEVEL OF MCP-1/CCL2 IN VITRO AND AT INFLAMMATORY SITES AND CONTROLS T CELL ACTIVATION IN RESPONSE TO ALLOANTIGEN 2002 ·Cytokine ·Laurie Tylaska,Landin Boring,(unknown),Robert J. Aiello,Israel Charo,Barrett J. Rollins,Ronald P. Gladue	55
10	IDENTIFICATION OF A HISTAMINE H₄RECEPTOR ON HUMAN EOSINOPHILS—ROLE IN EOSINOPHIL CHEMOTAXIS 2002 ·Journal of Receptors and Signal Transduction ·(unknown),(unknown),Stephen Jenkinson,Ronald P. Gladue,Shane Foo,Steven A. Trim,Beate Peter,Mike Trevethick,Mark Fidock	159
11	The anti-tumor activity of anti-CTLA-4 is mediated through its induction of IFNγ 2001 ·Cancer Immunology Immunotherapy ·Timothy Paradis,Eugenia Floyd,(unknown),(unknown),Brandon L. Brunson,Eileen A. Elliott,Steven C. Gilman,Ronald P. Gladue	34
12	Induction of Acute Inflammation In Vivo by Staphylococcal Superantigens. II. Critical Role for Chemokines, ICAM-1, and TNF-α 1998 ·The Journal of Immunology ·Philippe A. Tessier,Paul H. Naccache,Kerrilyn R. Diener,Ronald P. Gladue,Kuldeep Neote,Ian Clark‐Lewis,Shaun R. McColl	63
13	Early eosinophil infiltration into the optic nerve of mice with experimental allergic encephalomyelitis. 1998 ·PubMed ·Anthony J. Milici,(unknown),H Stukenbrok,(unknown),Ronald P. Gladue,Henry J. Showell	17
14	Transgenic monocyte chemoattractant protein-1 (MCP-1) in pancreatic islets produces monocyte-rich insulitis without diabetes: abrogation by a second transgene expressing systemic MCP-1 1997 ·The Journal of Immunology ·Iqbal S. Grewal,BARBARA J. RUTLEDGE,(unknown),Lin Gu,Ronald P. Gladue,R. A. Flavell,Barrett J. Rollins	125
15	Inhibition of leukotriene B4-receptor interaction suppresses eosinophil infiltration and disease pathology in a murine model of experimental allergic encephalomyelitis. 1996 ·The Journal of Experimental Medicine ·Ronald P. Gladue,(unknown),Anthony J. Milici,(unknown),H Stukenbrok,E. R. Pettipher,E.D. Salter,(unknown),Henry J. Showell	74
16	High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens 1995 ·The Journal of Immunology ·BARBARA J. RUTLEDGE,Helen Rayburn,R. Rosenberg,R J North,Ronald P. Gladue,Christopher L. Corless,Barrett J. Rollins	151
17	In vivo augmentation of IFN-γ with a rIL-12 human/mouse chimera: Pleiotropic effects against infectious agents in mice and rats 1994 ·Cytokine ·Ronald P. Gladue,(unknown),(unknown),(unknown),M.M. O'Donnell,Paul S. Changelian,Arthur E. Franke	14
18	THE PROTECTIVE EFFECTS OF THE THROMBOXANE SYNTHETASE INHIBITOR DAZMEGREL ON NEPHROTOXICITY IN CYCLOSPORINE-TREATED RATS 1991 ·Transplantation ·Ronald P. Gladue,(unknown)	7
19	In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells 1989 ·Antimicrobial Agents and Chemotherapy ·Ronald P. Gladue,G. Michael Bright,Richard E. Isaacson,M F Newborg	3
20	Enhanced antibacterial resistance in neutropenic mice treated with human recombinant interleukin-1 beta 1988 ·Inflammation Research ·Ronald P. Gladue,Agnès Girard,M F Newborg	25

About Ronald P. Gladue

Ronald P. Gladue is a scholar working on Immunology, Immunology and Allergy and Oncology, having authored 40 papers that have together received 3.0k indexed citations. Recurring topics across this work include Chemokine receptors and signaling (17 papers), Immunotherapy and Immune Responses (13 papers) and T-cell and B-cell Immunology (13 papers). The work is most often cited by research in Immunology (1.7k citations), Immunology and Allergy (270 citations) and Oncology (1.1k citations). Ronald P. Gladue has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Kuldeep Neote, M F Newborg, G. Michael Bright, Richard E. Isaacson, Timothy Paradis, Christine A. Strick, James G. Boyd, Shaun R. McColl, Bernhard Moser and Barbara G. Sahagan. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact